An abbott field service representative visited the customer site and verified no issues with the architect (b)(4) analyzer.No customer returns were available for this evaluation.A review of architect afp complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation.The product evaluation did not include any testing of the suspect reagent lot 32152lf00 as re-testing of the patient sample by the customer consistently generated the expected lower result, which indicates that the customer issue is not reagent lot specific.A review of the manufacturing documentation did not identify any issues associated with the customer issue.The architect afp assay package insert and the architect (b)(4) operations manual both contain information to address the current customer issue.Based on a review of the information from the customer site and the results of the current evaluation, it was determined that the architect afp assay, lot 32152lf00, is performing as expected.A product malfunction was not identified.
|